PharmaEssentia sets up a new R&D facility in the Boston Area
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Allam was serving recently as the CEO at Public Investment Fund
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Subscribe To Our Newsletter & Stay Updated